Literature DB >> 29306572

Novel biotin linker with alkyne and amino groups for chemical labelling of a target protein of a bioactive small molecule.

Tomoaki Anabuki1, Miu Tsukahara1, Masanori Okamoto2, Hideyuki Matsuura1, Kosaku Takahashi3.   

Abstract

We synthesized a novel linker (1) with biotin, alkyne and amino groups for the identification of target proteins using a small molecule that contains an azide group (azide probe). The alkyne in the linker bound the azide probe via an azide-alkyne Huisgen cycloaddition. A protein cross-linker effectively bound the conjugate of the linker and an azide probe with a target protein. The covalently bound complex was detected by western blotting. Linker 1 was applied to a model system using an abscisic acid receptor, RCAR/PYR/PYL (PYL). Cross-linked complexes of linker 1, the azide probes and the target proteins were successfully visualized by western blotting. This method of target protein identification was more effective than a previously developed method that uses a second linker with biotin, alkyne, and benzophenone (linker 2) that acts to photo-crosslink target proteins. The system developed in this study is a method for identifying the target proteins of small bioactive molecules and is different from photo-affinity labelling.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Abscisic acid; Crick reaction; PYL; Target protein identification

Mesh:

Substances:

Year:  2017        PMID: 29306572     DOI: 10.1016/j.bmcl.2017.12.055

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  AtTrxh3, a Thioredoxin, Is Identified as an Abscisic AcidBinding Protein in Arabidopsis thaliana.

Authors:  Tomoaki Anabuki; Keisuke Ohashi; Taichi E Takasuka; Hideyuki Matsuura; Kosaku Takahashi
Journal:  Molecules       Date:  2021-12-28       Impact factor: 4.411

2.  Cancer-targeted design of bioresponsive prodrug with enhanced cellular uptake to achieve precise cancer therapy.

Authors:  Yuanwei Liang; Wei Huang; Delong Zeng; Xiaoting Huang; Leung Chan; Chaoming Mei; Pengju Feng; Choon-Hong Tan; Tianfeng Chen
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.